Monday, February 19, 2018
Home Special Reports

Special Reports

BPA in inoperable CTEPH patients

Chronic thromboembolic pulmonary hypertension (CTEPH) is a common form of pulmonary hypertension. Up to 5% of patients who survive acute pulmonary embolism will develop...

It’s not all about inflammation

EU programmes at the Lund University Diabetes Centre, Sweden, provide novel insights into the mechanisms behind the development of cardiovascular disease in diabetes Cardiovascular disease...

Tilray – Advancing Cannabinoid Science

Tilray’s Medical Advisory Board facilitates ground-breaking advancements in cannabinoid science. Tilray, a Canadian federally-licensed global leader in medical cannabis research and production, is proud to...

The future of veterinary vaccines

Boehringer Ingelheim Vetmedica’s Dr Randolph Seidler discusses the emerging trends in veterinary vaccines Vaccines are an important arrow in the quiver of the veterinarian and...

Disaster as a discipline

The Emergency and Disaster Medicine Group of Vrije Universiteit Brussel, Belgium, asks how academia can help manage mass casualty situations. The Emergency and Disaster Medicine...

The Bavarian way of biobanking

The German Heart Center Munich sets an example for the combination of smart biobanking, biomarker research and data science High-quality biobanking for tissue and body...

The professionals

The head of KU Leuven’s Unit of Emergency Medicine, Marc Sabbe, considers the reactions of medical professionals in terror attacks Mass casualty incidents can no...

Vindicating vibrometry

Researchers from the Medtronic Bakken Research Centre in Maastricht, the Netherlands, explain the use of vibrometry in CVD detection Cardiovascular disease (CVD) encompasses diseases of...

The University of Genoa uses mesenchymal stem cells to treat neurodegenerative...

The University of Genoa uses mesenchymal stem cells from bone marrow to treat neurodegenerative diseases. Regenerative medicine represents a challenging area facing one of...

Vaccines versus the flu

Eurocine Vaccines plans clinical trials including the elderly in the influenza season, as Hans Arwidsson details Eurocine Vaccines (AktieTorget:EUCI) is planning its next clinical step...

Health News

Health eBooks

Health Partners

Pin It on Pinterest